News and Opinions

By Neuroscience News - Researchers have found that a ketogenic diet boosts CAR T cell therapy effectiveness by enhancing tumor control and survival in mice with lymphoma. The key is beta-hydroxybutyrate (BHB), a metabolite produced during ketosis, which CAR T cells...

by Dr Rinky Kapoor - Healthcare Radius - Exosomes, which are nanoscale extracellular vesicles derived from mesenchymal stem cells (MSCs), encapsulate a diverse array of bioactive molecules, including proteins, lipids, and nucleic acids, that facilitate intercellular...

by Bernice Lottering - Gene Online - Regenerative medicine, as a whole, is in a critical position to transform healthcare and confront several critical challenges that threaten its widespread adoption. High costs, complex development processes, and intricate...

By Benjamin Ferrer - Nutrition Insight - Scientists and physicians with the US-based cancer research and treatment organization City of Hope are presenting new research on high-fiber dietary interventions for bone marrow and stem cell transplant patients at risk for...

By Ayla Ellison, James Waldron - Fierce Biotech - After a promising start to the year, the biotech IPO market picked up steam again late this summer, with notable offerings from companies like Upstream, Septerna and BioAge. But what does this mean for the sector? Is...

By Science Direct - The management of neurological disorders is profoundly complicated by spinal cord injury (SCI), which leads to the impairment of motor and sensory functions. A major challenge in the treatment of SCI is the formation of a dysfunctional pathological...

By Dina Kupfer - CBS News - SACRAMENTO — A landmark clinical trial is underway at UC Davis Health: the world's first spina bifida treatment combining fetal surgery with stem cells. A child taking their first steps marks a major milestone, but for 20-month-old Nixon,...

By Susan Buckles - Mayo Clinic - Mayo Clinic's Center for Regenerative Biotherapeutics is collaborating with the biotech firm HepaTx on an experimental therapy to regenerate tissue in patients with late-stage liver disease. This new technology takes mesenchymal stem...

By Technology Networks - A novel CAR T-cell therapy has benefitted patients with relapsed acute lymphoblastic leukemia. Patients with relapsed or refractory CD19-positive B-cell acute lymphoblastic leukemia (ALL) who were treated with the novel anti-CD19 chimeric...

By Margarida Maia, PhD - Parkinson's News Today - The first six Parkinson’s disease patients given the investigational stem cell-based therapy TED-A9 in a clinical trial showed safety and an easing in their symptoms over one year of follow-up, the company developing...

By Nadine A Yehya - UCDavis Health - Funding promotes local production of CAR T-cell immunotherapy for cancer patients UC Davis Health’s Stem Cell Program has received a $500,000 grant from California health insurer Health Net to improve cancer patients’ access to...

By Caroline Seydel - Genetic Engineering & Biotechnology News - Parkinson’s disease is characterized by the loss of dopamine-producing neurons. The current treatment is oral levodopa, which is taken up by brain neurons and converted to dopamine. But levodopa...

By Stem Cells Translational Medicine - Mesenchymal stem cells (MSCs) hold tremendous potential for regenerative medicine and the treatment of currently incurable diseases. These adult multipotent progenitor cells are essential for tissue regeneration and wound repair...

by Lindsey Shapiro, PhD - ALS News Today - Answer ALS and Cedars-Sinai have made openly available their amyotrophic lateral sclerosis (ALS) patient-based stem cell and biodata repository to researchers worldwide. The largest of its kind, the repository contains...

By James Dinneen - New Scientist - Growing wood directly from stem cells could offer an alternative to cutting threatened hardwood trees, but it isn't clear if it has same properties as actual wood. What may be the world’s first piece of lab-grown wood isn’t quite big...

By VHIO - One-third of HER2-positive (HER2+) tumors express the P95HER2 protein, which associates with an aggressive form of breast cancer with a poorer prognosis. Investigators of the VHIO’s Growth Factors Group, and the Cancer Research Program of Hospital del Mar...

By The Engineer - Engineers at Nottingham University have 3D-printed blood-based regenerative materials that mimic natural healing processes and enhance recovery. Described in Advanced Materials, the ‘biocooperative’ materials combine a subject’s own blood with...

By Genetic Engineering and Biotechnology News Clinical trial results are showing the first successes against solid tumors for CAR-T cells. The findings offer hope for children with a group of deadly brain and spinal cord tumors, including a cancer called diffuse...

By Andis Robeznieks - American Medical Association - It is critically important to make health IT accessible for all and to achieve equitable adoption among aging patients, people with hearing and eyesight impairment, as well as those who live in communities...

by Emily Mullin - Wired - It’s been a year since the gene-editing treatment Casgevy was approved for sickle cell disease and a related blood disorder. It’s finally being infused into patients. Called Casgevy, the gene-editing treatment is for people with sickle cell...